Abstract
A short and practical synthesis for preparing the active pharmaceutical ingredient dolutegravir
sodium was investigated. The convergent strategy developed herein starts from 3-(R)-amino-1-
butanol and builds up the BC ring system in 76% isolated yield over four steps. Ring A was
constructed by a one-pot 1,4-addition to diethyl-(2E/Z)-2-(ethoxymethylidene)-3-oxobutandioate
and subsequent MgBr2·OEt2-mediated regioselective cyclization. Amide formation with 2,4-
difluorobenzylamine was either performed from the carboxylic acid or through aminolysis of the
corresponding ester precursor. Final salt formation afforded dolutegravir sodium in 48–51%
isolated yield (HPLC-purity: 99.7–99.9%) over six linear steps.



![Author ORCID: We display the ORCID iD icon alongside authors names on our website to acknowledge that the ORCiD has been authenticated when entered by the user. To view the users ORCiD record click the icon. [opens in a new tab]](https://www.cambridge.org/engage/assets/public/coe/logo/orcid.png)